Medical Science Liaison (MSL) – Launch Preparation

As we prepare for potential upcoming launches, Karyopharm is seeking to connect with experienced Medical Science Liaisons across the United States. Medical Science Liaisons at Karyopharm serve as trusted scientific partners to the medical community, engaging thought leaders and healthcare professionals across hematologic malignancies and solid tumors. Areas of focus may include multiple myeloma, myelofibrosis, endometrial cancer, and select rare diseases aligned with near-term launch readiness and longer-term pipeline development.